- Home
- CYCC vs SPRC Comparison
CYCC vs SPRC Comparison
Compare CYCC & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYCC
- SPRC
- Stock Information
- Founded
- CYCC 1992
- SPRC 2004
- Country
- CYCC United States
- SPRC Israel
- Employees
- CYCC N/A
- SPRC N/A
- Industry
- CYCC Biotechnology: Pharmaceutical Preparations
- SPRC Biotechnology: Pharmaceutical Preparations
- Sector
- CYCC Health Care
- SPRC Health Care
- Exchange
- CYCC Nasdaq
- SPRC Nasdaq
- Market Cap
- CYCC 3.6M
- SPRC 3.5M
- IPO Year
- CYCC N/A
- SPRC N/A
- Fundamental
- Price
- CYCC $0.25
- SPRC $0.30
- Analyst Decision
- CYCC Strong Buy
- SPRC
- Analyst Count
- CYCC 1
- SPRC 0
- Target Price
- CYCC $11.00
- SPRC N/A
- AVG Volume (30 Days)
- CYCC 160.2K
- SPRC 6.1M
- Earning Date
- CYCC 05-13-2025
- SPRC 02-15-2025
- Dividend Yield
- CYCC N/A
- SPRC N/A
- EPS Growth
- CYCC N/A
- SPRC N/A
- EPS
- CYCC N/A
- SPRC N/A
- Revenue
- CYCC $74,000.00
- SPRC $1,747,000.00
- Revenue This Year
- CYCC N/A
- SPRC N/A
- Revenue Next Year
- CYCC $88.68
- SPRC N/A
- P/E Ratio
- CYCC N/A
- SPRC N/A
- Revenue Growth
- CYCC N/A
- SPRC N/A
- 52 Week Low
- CYCC $0.22
- SPRC $0.20
- 52 Week High
- CYCC $4.00
- SPRC $2.10
- Technical
- Relative Strength Index (RSI)
- CYCC 29.30
- SPRC 39.37
- Support Level
- CYCC $0.29
- SPRC $0.27
- Resistance Level
- CYCC $0.32
- SPRC $0.39
- Average True Range (ATR)
- CYCC 0.02
- SPRC 0.03
- MACD
- CYCC -0.00
- SPRC 0.00
- Stochastic Oscillator
- CYCC 19.92
- SPRC 27.59
About CYCC Cyclacel Pharmaceuticals Inc.
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.
About SPRC SciSparc Ltd.
SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.